SlideShare a Scribd company logo
1 of 22
Download to read offline
 Phenomenon to complex formation with protein called
protein binding
 Divided as
 Intracellular: primary receptor: therapeutic effect
 Extracellular: : secondary or silent receptor: no p’cology action
Friday, May 18, 2018 2
 Bound Drug is Pharmacodynamicaly inert.
 Binding: Half life of drug.
 Generally reversible n weak chemical Bonding :
Hydrogen bond, Hydrophilic bond, ionic bond, Vander
Walls bond.
 Irreversible bonding : Covalent bonding : responsible
for the Carcinogenicity or Tissue toxicity.
Friday, May 18, 2018 3
To Blood
components
1. Plasma
Proteins
2. Blood
cells
To Extra
vascular
Tissues
1. Proteins
2. Fats
3. Bones ,
etc.
Friday, May 18, 2018 4
Friday, May 18, 2018 5
Friday, May 18, 2018 6
I) Plasma Protein Binding of drug:
 Reversible
 Order : Albumin > α1 Acid Glycoprotein > Lipoproteins
> Globulins.
 Involves binding to :
1. Human serum Albumin.
2. α1 Acid Glycoprotein,
3. Lipoproteins,
4. Globulins
Friday, May 18, 2018 7
 High potential of binding
 Having mol wt of 65,000
dalton
 depending on affinity
Primary site and
Secondary site:
 I n II responsible for most
binding
 Bond: Hydrophilic bond.
 Competitive inhibition
Friday, May 18, 2018 8
 Role is circulation of lipid to tissue through blood, similarly
transport drugs
 Binding by: Hydrophobic Bond. Non-competitive, depends
on partitioning, lipophilic
 Conc less than HAS n AAG, Mol wt : 2-3 lacks Dalton.
 Binded drug dissolves in Lipid core.
 Lipid Core composed of :
Inside: Triglycerides,
cholesterol esters,
Outside: Appoprotein.
 E.g :Acidic: Diclofenac.
Neutral: Cyclosporine A
Basic: Chlorpromazine.
Friday, May 18, 2018 9
 Binding by: Hydrophobic bonds.
 E.g. : Basic Drugs: Imipramine, Amytriptyline, Lidocaine.
4. Binding to Globulin
Friday, May 18, 2018 10
Globulin Synonym Binds to:
1. α1 Globulin Transcortine /Corticosteroid
Binding globulin
Steroidal drugs, Thyroxin
& Cyanocobalamine.
2. α2 Globulin Ceruloplasmine Vitamin A,D,E,K.
3. β1Globulin Transferine Ferrous ions
4. β2Globulin --- Carotinoids
5. γ Globulin --- Antigens
 Lipophilic drug enters fast
 40 % of Blood comprises of blood cells
 Majority is RBCs [95%]: 500 times more diameter as
Albumin.
 RBC Components that binds to drug:
Friday, May 18, 2018 11
Hb
• 64,500 mol wt, 7-8 times conc. of albumin
• Binds to: Phenytoins, Pentobarbital, Phenothiazine.
Carbonic
Anhydrase
• Binds to : Acetazolamide, Chlorthalidone,
Cell
membrane
• Binds to : Imipramine, Chlorpromazine.
 40% of total body wt/100times than HAS, so more imp
 Importance : 1. Apparent Vd.
2. Localization of drug at specific site :
irreversible binding so biological half life.
 Factors affecting : Lipophilicity, structural feature of
drug, Perfusion rate, pH difference.
 Binding Order : Liver > Kidney > Lungs > Muscle.
Friday, May 18, 2018 12
Organ Binding of:
1.Liver Irreversible binding of Epoxides of Halogenated
Hydrocarbon & Paracetamol.
2.Lungs Basic drugs : Imipramine, Chlorpromazine, &
AntiHistaminics.
3.Kidney Metallothione protein binds to Heavy metals & results in
Renal accumulation toxicity.
4.Skin Chloroquine & Phenothiazine binds to Melanin.
Organ Binding of:
5.Eye Chloroquine & Phenothiazine also binds to Eye Melanin &
results in Retinopathy.
6.Hairs Arsenicals, Chloroquine, & Phenothiazine.
7.Bones Tetracycline(yellow discoloration of teeth),
Lead(replaces Ca & cause brittleness)
8.Fats Lipophilic drugs (thiopental),
Pesticides (DDT)
9.Nucleic Acid Chloroquine & Quinacrin.
Friday, May 18, 2018 13
Plasma-protein Tissue-protein
Reve n weak bond Irr, strong bond
Small apparent VD Large AVD
Half-life relatively short Relatively long
Not cause toxicity Causes common
Displacement by another drug
possible
Generally not occur
Competition bet drug to bind Gen non-competitive
Friday, May 18, 2018 14
A)Drug Related:
1.Physicochemical Characteristics:
 Lipophilicity α binding.
 Anionic/Acidic binds : HAS
 Cationic/Basic binds : AAG
2. Concentration of Drug:
3.Drug protein/tissue affinity: Digoxine Affinity to
cardiac muscle.
B)Protein/Tissue Related:
1.Physicochemical Characteristics :
Lipophilicity α binding.
2. Concentration
Friday, May 18, 2018 15
 Alb. Has more.
 Tamoxifen & Dicumarol binds to 10 & 20 sites of alb.
 Indomethacine binds to 3 site.
C) Drug Interaction:
1.Competition between Drugs for binding site.
D1: Displaced Drug. D2: Displacer Drug.
E.g. Adm. Of Phenylbutazone to Warfarine therapy patient,
result in Hemorrhagic reaction.
Friday, May 18, 2018 16
D1+P
D2
D2+P
 FFA competes with HAS.
 FFA level increased during conditions :
 Physiological C. (Fasting)
 Pathological C. (Diabetes, M.I)
 Pharmacological (Heparin & Caffeine adm.).
 Acidic Drug displaces : Bilurubine from Alb. & results in
Kernictarus.
3.Allosteric Changes In Protein Molecule:
 By drug or its Metabolite.
 Allosteric Modulators: are agents responsible.
 E.g. Aspirins acetylating of Lysine of Alb. So modifying
capacity of NSAIDS binding.
Friday, May 18, 2018 17
1.Age:
Neonates: Low Alb. content: more free drug.
Young Infants: High dose of Digoxine due to large renal
clearance.
Elderly: Low Alb. : so more free drug.
2.Intersubject Variability: Due to Genetic & Environmental
Factors.
3. Disease State:
Friday, May 18, 2018 18
Disease Influence On Plasma
Proteins
Binding to
Acidic Basic Neutral
1.Renal failure Alb. contents No Effect No Effect
2.Hepatic failure Alb. Synthesis Normal or No Effect
3.Inflammatory
states
AAG level No Effect No Effect
 At distribution Equilibrium : Conc. of drug in body is
determined By: Vol. of Tissue in which drug is present.
 Different tissue have diff. conc. So Vd cannot have a
true physiologic meaning.
 (Amount of drug in body) α ( Conc. Of drug in plasma)
X α C
X = Vd. C
Def: Hypothetical Vol. of body fluid into which drug is
dissolved or distributed.
It is Apparent Vd : Because : All parts of body equilibrated
with drug do not have equal conc.
Friday, May 18, 2018 19
 Real Vd : has direct physiological meaning,
Is related to body water.
Friday, May 18, 2018 20
Body fluid Volume
(lit.)
% of
Body wt.
% of TWB
1.Vascular fluid
(plasma)
6
(3)
9
(4.5)
15
(7.5)
2.Extracellular fluid (excl plasma) 12 14 28
3.Intracellular fluid (excl blood
cells)
24 34 57
Total Body 42 60 100
Physiological fluid
compartment
Markers used Approximate vol.
1.Plasma Evans Blue, Indocyanine
Green, I-131 alb.
3
2.Erythrocytes Cr-51 2
3.Extracellular fluids Non metabolizable
saccharides like
Raffinose, Inuline,
Mannitol, & Radio
isotopes of selected ions:
Na+, Cl-, Br-, So4
2-.
15
Total body water D2O, HTO, Antipyrine 42
Friday, May 18, 2018 21
 D.M.Brahmankar & Sunil B.Jaiswal’s Biopharmaceutics &
Pharmacokinetics A Treatise, Vallabh Prakashan, New
Delhi, pg. no. 86-102.
 http://en.wikipedia.org/wiki/Volume_of_distribution
 www.pharmacy.ualberta.ca
 Presentation at ISPA Educational Workshop,
Copenhagen.
 www.hucmlrc.howard.edu/pharmacology
Friday, May 18, 2018 22

More Related Content

What's hot

Protein drug binding
Protein drug bindingProtein drug binding
Protein drug bindingSnehal Patel
 
H1and h2 receptors
H1and h2 receptorsH1and h2 receptors
H1and h2 receptorsSanjay Gopi
 
Antibiotics - Medicinal chemistry
Antibiotics - Medicinal chemistry Antibiotics - Medicinal chemistry
Antibiotics - Medicinal chemistry kencha swathi
 
Codes of pharmaceutical ethics
Codes of pharmaceutical ethicsCodes of pharmaceutical ethics
Codes of pharmaceutical ethicsAshish Chaudhari
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationSuvarta Maru
 
Medicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsMedicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsDHARMENDRA BARIA
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug DesignSagar Magar
 
Medicinal and toilet preparations act and rules,1955
Medicinal and toilet preparations act and rules,1955Medicinal and toilet preparations act and rules,1955
Medicinal and toilet preparations act and rules,1955Ganesh Shevalkar
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugswonderingsoul114
 
Synthesis of Alkylating agents
Synthesis of Alkylating agents Synthesis of Alkylating agents
Synthesis of Alkylating agents Saksham Palawat
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug bindingSagar Savale
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug designProf. Aejaz Ahmed Boraji
 
dihydrofolate reductase inhibitor
dihydrofolate reductase inhibitor dihydrofolate reductase inhibitor
dihydrofolate reductase inhibitor SarthakGupta190
 

What's hot (20)

Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
 
H1and h2 receptors
H1and h2 receptorsH1and h2 receptors
H1and h2 receptors
 
Antibiotics - Medicinal chemistry
Antibiotics - Medicinal chemistry Antibiotics - Medicinal chemistry
Antibiotics - Medicinal chemistry
 
Codes of pharmaceutical ethics
Codes of pharmaceutical ethicsCodes of pharmaceutical ethics
Codes of pharmaceutical ethics
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administration
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Antigout drugs
Antigout drugsAntigout drugs
Antigout drugs
 
Bioassay of Digitalis
Bioassay of DigitalisBioassay of Digitalis
Bioassay of Digitalis
 
Medicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agentsMedicinal chemistry-Anticancer agents
Medicinal chemistry-Anticancer agents
 
Concept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic modelConcept of non linear and linear pharmacokinetic model
Concept of non linear and linear pharmacokinetic model
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug Design
 
Medicinal and toilet preparations act and rules,1955
Medicinal and toilet preparations act and rules,1955Medicinal and toilet preparations act and rules,1955
Medicinal and toilet preparations act and rules,1955
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugs
 
Synthesis of Alkylating agents
Synthesis of Alkylating agents Synthesis of Alkylating agents
Synthesis of Alkylating agents
 
Hammett parameters
Hammett parametersHammett parameters
Hammett parameters
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug design
 
dihydrofolate reductase inhibitor
dihydrofolate reductase inhibitor dihydrofolate reductase inhibitor
dihydrofolate reductase inhibitor
 
Oxytocin bioassay
Oxytocin bioassayOxytocin bioassay
Oxytocin bioassay
 

Similar to Protein binding of drug

Protein Binding Of Drug.pptx
Protein Binding Of Drug.pptxProtein Binding Of Drug.pptx
Protein Binding Of Drug.pptxSkRahabar1
 
Proteinbindingofdrug 150217022700-conversion-gate02
Proteinbindingofdrug 150217022700-conversion-gate02Proteinbindingofdrug 150217022700-conversion-gate02
Proteinbindingofdrug 150217022700-conversion-gate02MANISH KUMAR
 
Plasmaproteins 120711133728-phpapp01
Plasmaproteins 120711133728-phpapp01Plasmaproteins 120711133728-phpapp01
Plasmaproteins 120711133728-phpapp01mohamed gazar
 
Protein binding unit 4 bppk pe 520 (final) [autosaved] (1)
Protein binding unit 4 bppk pe 520 (final) [autosaved] (1)Protein binding unit 4 bppk pe 520 (final) [autosaved] (1)
Protein binding unit 4 bppk pe 520 (final) [autosaved] (1)Priyansha Singh
 
proteindrugbinding-160428055046.pptx
proteindrugbinding-160428055046.pptxproteindrugbinding-160428055046.pptx
proteindrugbinding-160428055046.pptxssuser57769b
 
translational biotechnology-Amgen -Geeta Iyer -4-48-16
translational biotechnology-Amgen -Geeta Iyer -4-48-16translational biotechnology-Amgen -Geeta Iyer -4-48-16
translational biotechnology-Amgen -Geeta Iyer -4-48-16Geeta Iyer
 
actrec oncotherapeutics fellowship questions.pdf
actrec oncotherapeutics fellowship questions.pdfactrec oncotherapeutics fellowship questions.pdf
actrec oncotherapeutics fellowship questions.pdfDonaSunny3
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugsNaresh Gorantla
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
PharmacodynamicsAbhiDabra
 
Polymer therapeutics: an smart drug delivary system
Polymer therapeutics: an smart drug delivary systemPolymer therapeutics: an smart drug delivary system
Polymer therapeutics: an smart drug delivary systemAlok kumar Soni
 
Drug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteDrug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteArabinda Changmai
 

Similar to Protein binding of drug (20)

Protein Drug Binding
Protein Drug BindingProtein Drug Binding
Protein Drug Binding
 
bf
bfbf
bf
 
Protein binding of drugs2003
Protein binding of drugs2003Protein binding of drugs2003
Protein binding of drugs2003
 
Protein Binding Of Drug.pptx
Protein Binding Of Drug.pptxProtein Binding Of Drug.pptx
Protein Binding Of Drug.pptx
 
Proteinbindingofdrug 150217022700-conversion-gate02
Proteinbindingofdrug 150217022700-conversion-gate02Proteinbindingofdrug 150217022700-conversion-gate02
Proteinbindingofdrug 150217022700-conversion-gate02
 
Protein binding
Protein bindingProtein binding
Protein binding
 
Protein binding...pptx
Protein binding...pptxProtein binding...pptx
Protein binding...pptx
 
Plasmaproteins 120711133728-phpapp01
Plasmaproteins 120711133728-phpapp01Plasmaproteins 120711133728-phpapp01
Plasmaproteins 120711133728-phpapp01
 
Protein binding unit 4 bppk pe 520 (final) [autosaved] (1)
Protein binding unit 4 bppk pe 520 (final) [autosaved] (1)Protein binding unit 4 bppk pe 520 (final) [autosaved] (1)
Protein binding unit 4 bppk pe 520 (final) [autosaved] (1)
 
proteindrugbinding-160428055046.pptx
proteindrugbinding-160428055046.pptxproteindrugbinding-160428055046.pptx
proteindrugbinding-160428055046.pptx
 
translational biotechnology-Amgen -Geeta Iyer -4-48-16
translational biotechnology-Amgen -Geeta Iyer -4-48-16translational biotechnology-Amgen -Geeta Iyer -4-48-16
translational biotechnology-Amgen -Geeta Iyer -4-48-16
 
actrec oncotherapeutics fellowship questions.pdf
actrec oncotherapeutics fellowship questions.pdfactrec oncotherapeutics fellowship questions.pdf
actrec oncotherapeutics fellowship questions.pdf
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Protien binding of drugs
Protien binding of drugsProtien binding of drugs
Protien binding of drugs
 
PROTEIN BINDING OF DRUGS
PROTEIN  BINDING OF DRUGS PROTEIN  BINDING OF DRUGS
PROTEIN BINDING OF DRUGS
 
Biochemistry spotters
Biochemistry spottersBiochemistry spotters
Biochemistry spotters
 
Polymer therapeutics: an smart drug delivary system
Polymer therapeutics: an smart drug delivary systemPolymer therapeutics: an smart drug delivary system
Polymer therapeutics: an smart drug delivary system
 
Williams Az July
Williams Az JulyWilliams Az July
Williams Az July
 
Drug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteDrug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding site
 

More from Suvarta Maru

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus Suvarta Maru
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )Suvarta Maru
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discoverySuvarta Maru
 
Schedules of drugs
Schedules of drugsSchedules of drugs
Schedules of drugsSuvarta Maru
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterialsSuvarta Maru
 
Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trialsSuvarta Maru
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatmentSuvarta Maru
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDYSuvarta Maru
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDYSuvarta Maru
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)Suvarta Maru
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)Suvarta Maru
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSuvarta Maru
 

More from Suvarta Maru (20)

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discovery
 
USFDA & WHO
USFDA & WHOUSFDA & WHO
USFDA & WHO
 
US FDA
US FDA US FDA
US FDA
 
Toxicity slides
Toxicity slidesToxicity slides
Toxicity slides
 
TGA & MHRA
TGA & MHRATGA & MHRA
TGA & MHRA
 
Thermal analysis
Thermal analysisThermal analysis
Thermal analysis
 
Stroke study
Stroke studyStroke study
Stroke study
 
Schedules of drugs
Schedules of drugsSchedules of drugs
Schedules of drugs
 
Schedule m
Schedule  m Schedule  m
Schedule m
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
 
Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trials
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatment
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDY
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDY
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
New drug approval
New drug approvalNew drug approval
New drug approval
 

Recently uploaded

Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)cama23
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationRosabel UA
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptxiammrhaywood
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 

Recently uploaded (20)

Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translation
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 

Protein binding of drug

  • 1.
  • 2.  Phenomenon to complex formation with protein called protein binding  Divided as  Intracellular: primary receptor: therapeutic effect  Extracellular: : secondary or silent receptor: no p’cology action Friday, May 18, 2018 2
  • 3.  Bound Drug is Pharmacodynamicaly inert.  Binding: Half life of drug.  Generally reversible n weak chemical Bonding : Hydrogen bond, Hydrophilic bond, ionic bond, Vander Walls bond.  Irreversible bonding : Covalent bonding : responsible for the Carcinogenicity or Tissue toxicity. Friday, May 18, 2018 3
  • 4. To Blood components 1. Plasma Proteins 2. Blood cells To Extra vascular Tissues 1. Proteins 2. Fats 3. Bones , etc. Friday, May 18, 2018 4
  • 7. I) Plasma Protein Binding of drug:  Reversible  Order : Albumin > α1 Acid Glycoprotein > Lipoproteins > Globulins.  Involves binding to : 1. Human serum Albumin. 2. α1 Acid Glycoprotein, 3. Lipoproteins, 4. Globulins Friday, May 18, 2018 7
  • 8.  High potential of binding  Having mol wt of 65,000 dalton  depending on affinity Primary site and Secondary site:  I n II responsible for most binding  Bond: Hydrophilic bond.  Competitive inhibition Friday, May 18, 2018 8
  • 9.  Role is circulation of lipid to tissue through blood, similarly transport drugs  Binding by: Hydrophobic Bond. Non-competitive, depends on partitioning, lipophilic  Conc less than HAS n AAG, Mol wt : 2-3 lacks Dalton.  Binded drug dissolves in Lipid core.  Lipid Core composed of : Inside: Triglycerides, cholesterol esters, Outside: Appoprotein.  E.g :Acidic: Diclofenac. Neutral: Cyclosporine A Basic: Chlorpromazine. Friday, May 18, 2018 9
  • 10.  Binding by: Hydrophobic bonds.  E.g. : Basic Drugs: Imipramine, Amytriptyline, Lidocaine. 4. Binding to Globulin Friday, May 18, 2018 10 Globulin Synonym Binds to: 1. α1 Globulin Transcortine /Corticosteroid Binding globulin Steroidal drugs, Thyroxin & Cyanocobalamine. 2. α2 Globulin Ceruloplasmine Vitamin A,D,E,K. 3. β1Globulin Transferine Ferrous ions 4. β2Globulin --- Carotinoids 5. γ Globulin --- Antigens
  • 11.  Lipophilic drug enters fast  40 % of Blood comprises of blood cells  Majority is RBCs [95%]: 500 times more diameter as Albumin.  RBC Components that binds to drug: Friday, May 18, 2018 11 Hb • 64,500 mol wt, 7-8 times conc. of albumin • Binds to: Phenytoins, Pentobarbital, Phenothiazine. Carbonic Anhydrase • Binds to : Acetazolamide, Chlorthalidone, Cell membrane • Binds to : Imipramine, Chlorpromazine.
  • 12.  40% of total body wt/100times than HAS, so more imp  Importance : 1. Apparent Vd. 2. Localization of drug at specific site : irreversible binding so biological half life.  Factors affecting : Lipophilicity, structural feature of drug, Perfusion rate, pH difference.  Binding Order : Liver > Kidney > Lungs > Muscle. Friday, May 18, 2018 12 Organ Binding of: 1.Liver Irreversible binding of Epoxides of Halogenated Hydrocarbon & Paracetamol. 2.Lungs Basic drugs : Imipramine, Chlorpromazine, & AntiHistaminics. 3.Kidney Metallothione protein binds to Heavy metals & results in Renal accumulation toxicity. 4.Skin Chloroquine & Phenothiazine binds to Melanin.
  • 13. Organ Binding of: 5.Eye Chloroquine & Phenothiazine also binds to Eye Melanin & results in Retinopathy. 6.Hairs Arsenicals, Chloroquine, & Phenothiazine. 7.Bones Tetracycline(yellow discoloration of teeth), Lead(replaces Ca & cause brittleness) 8.Fats Lipophilic drugs (thiopental), Pesticides (DDT) 9.Nucleic Acid Chloroquine & Quinacrin. Friday, May 18, 2018 13
  • 14. Plasma-protein Tissue-protein Reve n weak bond Irr, strong bond Small apparent VD Large AVD Half-life relatively short Relatively long Not cause toxicity Causes common Displacement by another drug possible Generally not occur Competition bet drug to bind Gen non-competitive Friday, May 18, 2018 14
  • 15. A)Drug Related: 1.Physicochemical Characteristics:  Lipophilicity α binding.  Anionic/Acidic binds : HAS  Cationic/Basic binds : AAG 2. Concentration of Drug: 3.Drug protein/tissue affinity: Digoxine Affinity to cardiac muscle. B)Protein/Tissue Related: 1.Physicochemical Characteristics : Lipophilicity α binding. 2. Concentration Friday, May 18, 2018 15
  • 16.  Alb. Has more.  Tamoxifen & Dicumarol binds to 10 & 20 sites of alb.  Indomethacine binds to 3 site. C) Drug Interaction: 1.Competition between Drugs for binding site. D1: Displaced Drug. D2: Displacer Drug. E.g. Adm. Of Phenylbutazone to Warfarine therapy patient, result in Hemorrhagic reaction. Friday, May 18, 2018 16 D1+P D2 D2+P
  • 17.  FFA competes with HAS.  FFA level increased during conditions :  Physiological C. (Fasting)  Pathological C. (Diabetes, M.I)  Pharmacological (Heparin & Caffeine adm.).  Acidic Drug displaces : Bilurubine from Alb. & results in Kernictarus. 3.Allosteric Changes In Protein Molecule:  By drug or its Metabolite.  Allosteric Modulators: are agents responsible.  E.g. Aspirins acetylating of Lysine of Alb. So modifying capacity of NSAIDS binding. Friday, May 18, 2018 17
  • 18. 1.Age: Neonates: Low Alb. content: more free drug. Young Infants: High dose of Digoxine due to large renal clearance. Elderly: Low Alb. : so more free drug. 2.Intersubject Variability: Due to Genetic & Environmental Factors. 3. Disease State: Friday, May 18, 2018 18 Disease Influence On Plasma Proteins Binding to Acidic Basic Neutral 1.Renal failure Alb. contents No Effect No Effect 2.Hepatic failure Alb. Synthesis Normal or No Effect 3.Inflammatory states AAG level No Effect No Effect
  • 19.  At distribution Equilibrium : Conc. of drug in body is determined By: Vol. of Tissue in which drug is present.  Different tissue have diff. conc. So Vd cannot have a true physiologic meaning.  (Amount of drug in body) α ( Conc. Of drug in plasma) X α C X = Vd. C Def: Hypothetical Vol. of body fluid into which drug is dissolved or distributed. It is Apparent Vd : Because : All parts of body equilibrated with drug do not have equal conc. Friday, May 18, 2018 19
  • 20.  Real Vd : has direct physiological meaning, Is related to body water. Friday, May 18, 2018 20 Body fluid Volume (lit.) % of Body wt. % of TWB 1.Vascular fluid (plasma) 6 (3) 9 (4.5) 15 (7.5) 2.Extracellular fluid (excl plasma) 12 14 28 3.Intracellular fluid (excl blood cells) 24 34 57 Total Body 42 60 100
  • 21. Physiological fluid compartment Markers used Approximate vol. 1.Plasma Evans Blue, Indocyanine Green, I-131 alb. 3 2.Erythrocytes Cr-51 2 3.Extracellular fluids Non metabolizable saccharides like Raffinose, Inuline, Mannitol, & Radio isotopes of selected ions: Na+, Cl-, Br-, So4 2-. 15 Total body water D2O, HTO, Antipyrine 42 Friday, May 18, 2018 21
  • 22.  D.M.Brahmankar & Sunil B.Jaiswal’s Biopharmaceutics & Pharmacokinetics A Treatise, Vallabh Prakashan, New Delhi, pg. no. 86-102.  http://en.wikipedia.org/wiki/Volume_of_distribution  www.pharmacy.ualberta.ca  Presentation at ISPA Educational Workshop, Copenhagen.  www.hucmlrc.howard.edu/pharmacology Friday, May 18, 2018 22